ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G Report for Virax Biolabs Group Ltd Ordinary shares, par value $0.001 per share (VRAX)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Virax Biolabs Group Ltd Ordinary shares, par value $0.001 per share
Symbol: VRAX
Shares outstanding: 8,247,337 shares
Disclosed Ownership: 823,909 shares
Ownership: 10%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 21:42:16 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	10%	823,909	0	823,909	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	10%	823,909	0	823,909	/s/ Steven Boyd	Steven Boyd